SWISSNEX AWARD FOR THE MOST INNOVATIVE START-UP/ ENTREPRENEUR.
Cellestia Biotech AG
Cellestia is a clinical stage biotech company located in Basel, developing innovative first-in-class cancer drugs. The Cellestia management brings a unique blend of research, pharma drug development and business expertise. Through its innovative discovery platform, Cellestia has targeted a previously considered-undruggable protein complex. Cellestia’s novel anti-cancer drug is being tested in cancer patients in Europe, with planned expansion into China and the USA. Our lead drug has shown exceptional safety in humans. Due to its potential social and health benefit to cancer patients worldwide, Cellestia is a strong contender for this years’ Business Award for most innovative Start-Up/Entrepreneur.
BUSINESS AWARD FOR INNOVATION AND CREATIVE INDUSTRIES 4.0.
ABB – Gaoce
Established in 2006, Qingdao Gaoce Technology Co., Ltd. is a high-tech enterprise renowned at home and abroad relying on the core technologies in automatic detection and control, mechanical designing and high hardness brittle material cutting. ABB is a technology leader that is driving the digital transformation of industries with four globally leading businesses: Electrification, Industrial Automation, Motion, and Robotics & Discrete Automation, supported by the ABB Ability™ digital platform. Joining hands with ABB, Gaoce has successfully applied AI algorithms and models to its monocrystal silicon cutting process, using machine learning to predict equipment failures. ABB and Gaoce started a new strategic cooperation for collaborative innovation on a broader scale.
NESTLE AWARD FOR OUTSTANDING ACHIEVEMENTS OF AN SME.
Geistlich Pharma AG
Geistlich Pharma is a Swiss family-owned company existing since 1851.Today Geistlich Pharma is specialized in biomaterials for the regeneration of bone, cartilage and tissue with the goal of giving patients a better quality of life. The products are marketed worldwide. China represents the company’s largest market in terms of Sales and growth. The company has decisively shaped the market for regenerative biomaterials for decades. Geistlich Pharma is participating in the 2019 SSBA to serve as an example how a Swiss SME can become a dominant player in a niche-market in China through quality, highly innovative products and the pioneering spirit to achieve great things. The success story should serve as a motivation for other companies to venture for a similar journey.
BUSINESS AWARD FOR OUTSTANDING ACHIEVEMENTS OF AN MNC.
Shanghai Roche Pharmaceuticals Ltd.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. As a multinational pharmaceutical company, Roche took the lead in building a complete pharmaceutical value chain, providing Chinese patients with breakthrough medicines in many key therapeutic areas. As the first multinational pharmaceutical company to set up operations in Zhangjiang, Roche currently has covered eight therapeutic areas with 20 products in China. Meanwhile, Roche constantly strengthens its investments in China, especially in R&D innovation, with RMB 863 million investment toward the development of a new world-class innovation centre in Shanghai, which will innovatively bring differentiated value to Chinese patients.
CHINA NOBLENESS AWARD FOR THE MOST CHINA-READY SWISS WINTER DESTINATION.
Jungfrau Ski Region (JSR)
Jungfrau Ski Region (JSR) is one of the largest Winter destinations in the alps and is embedded at the very heart of Switzerland: The Bernese Oberland. With its two valleys and three Skiing areas (Grindelwald-First, Grindelwald-Wengen and Schilthorn) it offers a wide variety of slopes for skiers of all levels in front of the most impressive Swiss skyline: Eiger, Mönch and Jungfrau. JSR combines 100 years of experience in winter tourism with a once-in-a-century investment, achieving shorter travel times and more comfort for all visitors: The V-Project opening in 2020. The initial spark for our innovation flew thanks to JSR’s extensive network of tourism partners in China and – most importantly – the readiness to embrace and satisfy our Chinese guests in every way.
BUSINESS AWARD FOR OUTSTANDING CONTRIBUTION TO SPORTS.
Shankai Sports is the leading international sports management company in China, founded in 2009 by a team of Chinese and Swiss sports and business professionals. It provides sports business solutions to international sports organisations targeting the Chinese market, and to Chinese entities seeking to go global. Shankai’s business covers the areas of sponsorship, sports travel, licensed merchandise, event operation and media management. Shankai acts as the bridge between China, a burgeoning sports market, and Switzerland, the home of international sports. Shankai has created high-profile, groundbreaking business opportunities that have benefitted both China and Switzerland. No company has done more to bring the two countries closer in the field of sport than Shankai.
NESTLE AWARD FOR SUSTAINABILITY, DIVERSITY & SOCIAL RESPONSIBILITY.
FRAISA (SHANGHAI) CO., LTD.
Long-standing commitment and sustainable development are values that shape FRAISA‘s corporate philosophy. In the financial year, 140’000 francs was spent for supporting local community activities, and 7 jobs are created in China. 8% of profit was invested into R&D, automation and process optimization for sustainable development. Fraisa is also working together with other 20 Swiss companies to promote Sino-Swiss trade in the Metalworking industry. Fraisa produces state-of-the-art cutting tools for metalworking industry. The company was founded in 1934 and with its 547 employees. As a Swiss family business go for globalization, Fraisa started its activity in China since 2011 by establishing its Rep office. In 2018, with a capital injection, it transferred to WFOE.
BUSINESS AWARD FOR THE BEST CHINESE INNOVATOR/ INVESTOR.
The SinoSwiss Technopark (SSTP) is a private invested industrial park in Chongqing, with a physical presence in Switzerland. Besides being a self-contained physical hub, SSTP has established one of the most comprehensive Switzerland-China networks for generating sustainable partnerships between Swiss start-ups/SMEs and Chinese partners. SSTP is nominee at the SSBA 2019 in the category for the best Chinese Investor, because of its commitment to continuously work on facilitating the establishment of Swiss companies in China. A total investment sum of 200 million USD has been invested for the construction and operation of the park, and an additional 20 million USD has been prepared for the construction of a 6’000 m2 shared office and event facility in Switzerland.